Evolution of multiple sclerosis treatment: next generation therapies meet next generation efficacy criteria
Lancet Neurol
.
2011 Apr;10(4):293-5.
doi: 10.1016/S1474-4422(11)70043-6.
Authors
Hans-Peter Hartung
1
,
Orhan Aktas
Affiliation
1
Multiple Sclerosis Center, Department of Neurology, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany. hans-peter.hartung@uni-duesseldorf.de
PMID:
21397566
DOI:
10.1016/S1474-4422(11)70043-6
No abstract available
Publication types
Comment
MeSH terms
Humans
Multiple Sclerosis / therapy*